Genome Analysis Across Populations in Inflammatory Bowel Disease

Recruiting now

Conditions studied: Ulcerative Colitis, Healthy, Crohn Disease, Inflammatory Bowel Diseases

In brief

Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.

Key facts

Study ID

NCT06042387

Run by

Mount Sinai Hospital, Canada

People needed

150

Starts

2022-05-01

Expected to finish

2027-09-01

Last updated by the study team

2025-03-25

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined)
• Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U))
• Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss
• Any age

You may not qualify if…

• Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria

Where it is running

• Sinai Health System — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.